Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Bought by Trillium Asset Management LLC

Trillium Asset Management LLC grew its position in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 3.6% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 82,923 shares of the medical instruments supplier’s stock after purchasing an additional 2,851 shares during the period. Trillium Asset Management LLC owned approximately 0.14% of Merit Medical Systems worth $6,936,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC lifted its stake in Merit Medical Systems by 486.4% during the first quarter. Tower Research Capital LLC TRC now owns 1,466 shares of the medical instruments supplier’s stock worth $108,000 after purchasing an additional 1,216 shares in the last quarter. Victory Capital Management Inc. increased its position in shares of Merit Medical Systems by 18.5% during the second quarter. Victory Capital Management Inc. now owns 66,258 shares of the medical instruments supplier’s stock worth $5,542,000 after acquiring an additional 10,343 shares during the period. New York State Teachers Retirement System increased its position in shares of Merit Medical Systems by 0.5% during the second quarter. New York State Teachers Retirement System now owns 81,873 shares of the medical instruments supplier’s stock worth $6,848,000 after acquiring an additional 423 shares during the period. Virtu Financial LLC purchased a new stake in shares of Merit Medical Systems during the first quarter worth $294,000. Finally, Skandinaviska Enskilda Banken AB publ purchased a new stake in shares of Merit Medical Systems during the first quarter worth $1,974,000. 93.16% of the stock is currently owned by institutional investors and hedge funds.

Merit Medical Systems Stock Performance

NASDAQ MMSI traded up $0.44 during trading hours on Thursday, hitting $72.58. The company had a trading volume of 12,756 shares, compared to its average volume of 297,894. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.50 and a current ratio of 3.13. Merit Medical Systems, Inc. has a 1-year low of $62.58 and a 1-year high of $85.62. The company has a market cap of $4.19 billion, a PE ratio of 41.70, a price-to-earnings-growth ratio of 2.08 and a beta of 0.93. The business has a 50 day moving average of $67.73 and a 200-day moving average of $74.57.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Thursday, October 26th. The medical instruments supplier reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.10. Merit Medical Systems had a net margin of 8.17% and a return on equity of 14.71%. The company had revenue of $315.23 million during the quarter, compared to the consensus estimate of $306.25 million. As a group, equities research analysts expect that Merit Medical Systems, Inc. will post 2.96 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on MMSI shares. Piper Sandler upped their price objective on Merit Medical Systems from $85.00 to $92.00 and gave the stock an “overweight” rating in a research report on Friday, July 21st. Barrington Research upped their price objective on Merit Medical Systems from $95.00 to $96.00 and gave the stock an “outperform” rating in a research report on Friday, October 27th. Canaccord Genuity Group dropped their target price on Merit Medical Systems from $86.00 to $70.00 and set a “hold” rating on the stock in a report on Monday, August 28th. StockNews.com raised Merit Medical Systems from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, Needham & Company LLC dropped their target price on Merit Medical Systems from $96.00 to $81.00 and set a “buy” rating on the stock in a report on Friday, October 27th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and an average price target of $85.50.

Insider Transactions at Merit Medical Systems

In other news, COO Neil Peterson sold 8,000 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $67.91, for a total transaction of $543,280.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 3.70% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.